US health officials are investigating reports that Modern Inc.’s COVID-19 vaccine may be linked to higher risk of rare heart condition in young adults than previously thought Washington Post reported late Thursday, citing people familiar with the review.
The report quoted a source as saying that it is too early for regulators to reach any conclusions and additional work is needed before any recommendations can be made.
In June health regulators added a warning to the literature with the mRNA vaccines produced by Moderna and pfizer To characterize the rare risk of heart inflammation seen mainly in young men. However, he added that the benefits of the shots outweigh the risks in preventing COVID-19.
The incidence of myocarditis may be 2.5 times higher in those receiving the Moderna vaccine compared to the Pfizer vaccine, Post Quoting a source.
According to the report, the investigation focused on data from Canada suggests that the risk of myocarditis may be particularly high for men in their 30s or younger.
The report quoted a source as saying that it is too early for regulators to reach any conclusions and additional work is needed before any recommendations can be made.
In June health regulators added a warning to the literature with the mRNA vaccines produced by Moderna and pfizer To characterize the rare risk of heart inflammation seen mainly in young men. However, he added that the benefits of the shots outweigh the risks in preventing COVID-19.
The incidence of myocarditis may be 2.5 times higher in those receiving the Moderna vaccine compared to the Pfizer vaccine, Post Quoting a source.
According to the report, the investigation focused on data from Canada suggests that the risk of myocarditis may be particularly high for men in their 30s or younger.
.